|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Amortization of deferred contract acquisition costs | |||||
| Provision for allowance for doubtful accounts and billing reserves | |||||
| Non-cash lease expense | |||||
| Accretion of marketable securities | |||||
| Lease impairment charge | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Deferred contract acquisition costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Acquisition, net of cash acquired | |||||
| Purchase of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from initial public offering, net of underwriting discounts | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under ESPP | |||||
| Payment of tax withholding obligations related to net share settlements on equity awards | |||||
| Payment for repurchase of common stock | |||||
| Payment of cash dividend | |||||
| Repayment of short-term financing and equipment loans | |||||
| Repayment of finance lease obligations | |||||
| Payments of offering costs | |||||
| Acquisition holdback payment | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for taxes, net of refunds | |||||
| Cash paid for interest | |||||
| Supplemental disclosures of noncash investing and financing activities: | |||||
| Equipment acquired under finance leases | |||||
| Equipment purchased funded by liabilities | |||||
| Property and equipment purchased funded by liabilities | |||||
| Property and equipment purchased not yet paid | |||||
| Conversion of convertible preferred stock and redeemable convertible preferred stock to common stock | |||||
| Option exercises not yet settled | |||||
| Non-cash options exercise | |||||
| Holdback liability related to acquisition | |||||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other assets, non-current | |||||
Loading...